Back to Candriam S.C.A. Candriam S.C.A.

CTMXCTMX
15 quarters

Position history for Candriam S.C.A.Candriam S.C.A.'s holdings in CYTOMX THERAPEUTICS INC.

Candriam S.C.A. previously held 0 shares of CTMX (CYTOMX THERAPEUTICS INC.), worth $0 as of 2024-Q3.

Final Value

$0

Final Shares

0

Total Value Change

-$7.2M

Total Shares Change

-668,833

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2024-Q3
Latest
Exited
0
-100.0%
$00.0%$1.20
0
2024-Q2
New
210,027
-
$256,2210.0%$1.22
32
2022-Q3
Exited
0
-100.0%
$00.0%$1.47
0
2022-Q2
Unchanged
1.7M
0.0%
$3M0.0%$1.87
0
2022-Q1
Decreased
1.7M
-6.1%
$4.4M0.0%$2.77
0
2021-Q4
Decreased
1.8M
-46.7%
$7.6M0.0%$4.40
0
2021-Q3
Increased
3.3M
+42.0%
$16.8M0.1%$4.93
45
2021-Q2
Increased
2.3M
+15.9Kx
$14.7M0.1%$6.47
54
2021-Q1
New
146
-
$1,0000.0%$7.40
17
2020-Q2
Exited
0
-100.0%
$00.0%$8.21
0
2020-Q1
Increased
741,191
+0.0%
$6M0.1%$6.70
27
2019-Q4
Increased
741,144
+7.8%
$6.2M0.1%$8.29
29
2019-Q3
Unchanged
687,833
0.0%
$5.1M0.1%$7.70
0
2019-Q2
Increased
687,833
+2.8%
$7.7M0.1%$11.22
28
2019-Q1
New
668,833
-
$7.2M0.1%$10.75
38

Other major holders of CTMX: FMR LLC, BlackRock, Inc., BNP PARIBAS FINANCIAL MARKETS

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used